chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid heart rate 15 hours after first shot. Lasted an hour. Now comes and goes.  Rapid dehydration. 15 hours after shot. Tingling neck and jaw area. Days 1 and 4 Tightening in throat. Days 1 and 4 Pain in stomach. Day 4
Pneumovax 23 (Merck) Lot#0651Z, in Left Deltoid Swelling red rash, extremely tender to touch
About 10 days or so after the 2nd injection I had a flareup of Shingles across my face. Have not had a flareup in 6 years. Very coincidental. Went to doctor and had a course of acyclovir for 10 days that brought it back about 80% but had to set a second course to pretty much stop it. It appears to be acting up again. I am not happy!!
pt recvd vax; fever for 3 days per mom;somewhat disconnected for 4 days; had a large lump at inj site per mom; no dx tests performed
Information has been received from a nurse practitioner concerning a 49 yr old white male with type 1 diabetes mellitus and a penicillin allergy and no illness at the time of vaccination who at 3:00PM on 04Jun04 was vaccinated IM in the left arm with a first dose of pneumococcal 23v polysaccharide vaccine (lot 647797/0987N). Concomitant therapy included insulin lispro (Humalog). On 04Jun04, within 4 hrs of vaccination, the pt developed left arm swelling at injection site, fever, nausea and shortness of breath. On 06Jun04 the pt experienced ringing in ears, tingling and numbness on left side of face and headache. The pt was seen and treated with hydroxyzine HC1 (Atarax) 25mg and ibuprofen 800 mg (Motrin) 3 times daily. Additional information was received from the nurse practitioner who reported that the pt was contacted for follow up. The pt stated that the tingling sensation of his face and headache as well as the left arm swelling subsided after 3 days. The pt fully recovered on 09Jun04. No additional information is expected.
Information has been received from an investigator concerning a 26 month old female child who received Prevnar on 8/25/00 and the next day, the child was taken to a local clinic for urticaria and angioedema. The child has since recovered. Angioedema was considered a "Medically Important Event". Both the investigator and the medical monitor agree that this event was 'possibly' related to vaccine administration. Follow up information received 03/09/2001 clarified that the patient did not experience angioedema as previously reported. The patient experienced urticaria only. Therefore, this report has been downgraded to non-serious.
Redness; is also warm to touch; , more subcutaneous than muscle; have joint pain/ Pain in elbow; and headache; This case was reported by a nurse via call center representative and described the occurrence of joint pain in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of headache (received 1st dose on 29th November 2019, refer case US2020019106).   On 31st January 2020, the patient received the 2nd dose of Shingrix (subcutaneous). On 31st January 2020, less than a day after receiving Shingrix, the patient experienced joint pain, headache and intramuscular formulation administered by other route. On 2nd February 2020, the patient experienced erythema and skin warm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the joint pain and erythema were not recovered/not resolved and the outcome of the headache and skin warm were recovering/resolving and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the joint pain, headache, erythema and skin warm to be related to Shingrix.  Additional case details were reported as follows: The case was reported by patient's wife. The reporter believed that the vaccine was given too low and too anterior on the arm, which led to intramuscular formulation administered by other route. The band aid was low on the anterior part of his arm, more subcutaneous than muscle.  The reporter called pharmacy to inform them but by paperwork it notes the vaccine was given IM. After the vaccination, the patient began to have joint pain and headache.  On 1st February 2020, these issues continued. On 2nd February 2020, the patient's left elbow hurt really bad and on the day of reporting, it continued to be really sore.  The reporter also noted the area of redness was marked on 2nd February 2020 and on the day of reporting it was even larger.  The reporter stated it was also warm to touch. The reporter was encouraged to have her husband notify his physician. The reporter consented to follow up. This case has been linked with case US2020019097, reported for same reporter.
Apnea, limpness, color change (gray color, pale, blue lips), fever.
fever of 100.5°F and Head ache; fever of 100.5°F and Head ache; the arm is sore at the injection site; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fever of 100.5°f(Pyrexia) , head ache(Headache), the arm is sore at the injection site(Injection site pain).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (batch number: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) fever of 100.5°F and Head ache, the arm is sore at the injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of event(s), fever of 100.5°f and head ache, the arm is sore at the injection site was unknown.
Went to bed at 12 am, woke up in morning at 10:00 AM and noticed tenderness under arm.  This is the same arm where I received vaccine Afluria previous day. Lymph node is swollen and tender.
mom states started breaking out week of inj site & has generalized over body;denies fever;vesicle LPN noted small irregular shaped gen on body-sold red elevations noted on back/legs;
Headache, nausea, chills, overall body aches, drowsiness, hot flashes, arm rash at injection site
STROKE; This spontaneous report received from a consumer via a company representative concerned a male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, as per the reporter "a friend is in rehab from a stroke due to a blood clot. He too JJ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211263238-covid-19 vaccine ad26.cov2.s-stroke. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Per pt., started to experience arm pain not discomfort a couple of hours after injection, temperature variations (94-98), and a feeling of fuzziness. No other changes to diet or routine besides Influenza vaccine and TB test administered a couple of hours prior. Informed pt. that employee health nurse would be making a VAERS report in which she verbalized understanding. Pt. states that she has had some minor reactions to other vaccines before. Informed pt. to consult PCP in regards to reaction to Influenza vaccine in which she verbalized understanding.
Shingles a week after I got the shot; Awful pain; Left scars on my back; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles, pain and scar. On an unknown date, the outcome of the shingles and pain were unknown and the outcome of the scar was not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and scar to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got shingles one week after shingles shot. The pain was awful and it left with scars on his/her back. This case has been linked with US2021AMR190908 reported for same comment.
Leukemia diagnosed several years ago that was back since the vaccination; Lungs filled with liquid; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) as a single dose, route of administration and therapy date unspecified, for COVID-19 immunization. Medical history included agent orange exposure, and leukemia that was diagnosed several years ago. The patient's concomitant medications were not reported. On an unspecified date, the patient's leukemia that was diagnosed several years ago had been back since the vaccination; and the patient's lungs were filled with liquid. The patient was in a care home. The outcome of the events was unknown.  Information about lot/batch number has been requested.
with in 3.5 hours of shot my left pinky and outer left arm felt numbness; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number and Expiration date: unknown) via an unspecified route of administration in left arm on 13Apr2021 at 12:30 (age at vaccination 59-year-old) as single dose for covid-19 immunization. The patient medical history was none. Patient did not have any allergies to medications, food, or other products. The patient concomitant medication included acetylsalicylic acid [ASPIRIN (E.C.)] taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number and Expiration date: unknown) via an unspecified route of administration in left arm on 24Mar2021 at 03:00 PM as single dose for Covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to covid vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced within 3.5 hours of shot her left pinky and outer left arm felt numbness (on 13Apr2021 16:00. Patient did not receive any treatment for adverse event. The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
COVID break through Case. I received my 2nd booster shot on 04/14/2022. I tested positive for COVID 05/28/2022. I was also positive on 05/30/2022. My symptoms on 05/28/2022 were fever, headache, lack of energy, cough, joints aches, shortness of breath. I did a tele health on 05/29/2022  and my doctor prescribed me PAXLOVID and Aspirin. I took it for 5 days. As of now am still testing positive. My headache, cough, fever, joint aches are gone. I just have lack of energy. I will take a COVID home test on 06/09/2022 because am planning to travel if it's not negative I will not travel.
Pt 17 yrs old. Clinic required 18+ , no other adverse reactions.
After injection done, pt experienced a nod at the injection site. A large circle around the injection site. A redness area turned into a rash with little dots all over it around the injection site after a week. Pt came in on Saturday, May 13 and RPh recommended her BENADRYL cream plus  BENADRYL capsules. Pt applied cream not taking the capsules. Now, it starts spreading around and going down to the elbow area.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 65-year-old male patient who received SHINGRIX (batch number EH9Z7, expiry date 8th March 2021) for prophylaxis. On 26th September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In September 2018, less than a week after receiving SHINGRIX, the patient experienced contusion. On 27th September 2018, the patient experienced injection site pain and injection site swelling. On an unknown date, the outcome of the injection site pain and injection site swelling were recovering/resolving and the outcome of the contusion was not recovered/not resolved. It was unknown if the reporter considered the injection site pain, contusion and injection site swelling to be related to SHINGRIX. Additional information received as follows: The patient received SHINGRIX in the left deltoid. Within 48 hours after receiving SHINGRIX, the patient experienced a pretty bad looking bruise under the shoulder muscle.
PT. RECIEVED FLUAD AND SPIKEVAX IN THE SAME ARM ON 10.25.23. PT. REPORTED THE INJECTION SITE WAS VERY PAINFUL AND BROUGHT THE PT. TO TEARS. THE PATIENT ALSO REPORTED DISCOLORATION (POSSIBLE REDNESS) AT THE INJECTION SITE AS WELL. THE PHARMACY WAS MADE AWARE OF THE ADVERSE EFFECTS ON 10.31.23.
Information has been received from a consumer concerning her 15 year old daughter, who on 17-OCT-2007 was vaccinated with Gardasil vaccine. Concomitant therapy included Allegra and unspecified thyroid medication. On 29-OCT-2007, the patient experienced a low fever and nausea. The patients low fever and nausea persisted. No other symptoms were noted. A similar adverse experience was reported for the consumers other daughter, refer to WAES#0711USA00200. Additional information has been requested.
After receiving the vaccine on Saturday afternoon, the right arm started hurting(normal side effect) but by late Sunday afternoon (24 hours later) the lymph nodes in my right armpit started swelling.  The size of a plum as of Monday afternoon.  (48 hours)
rash started 3DEC94 on top of feet, Sunday 4DEC94 spread to stomach, inside of legs, palms of hands, under arms, buttocks, goes away @ one site & reappears @ another site;
I got COVID.  I had symptoms on 6/26/2022 and tested positive on 6/27/2022
Inadvertently was given Janssen vaccine at age 16.  Patient's mother reports that Avery had fever of 101, fatigue, and 'flu like' symptoms which fully resolved by April 3.  Avery has been feeling well since.
Flu; Initial information was received on 15-Oct-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional via media.  This case was linked to case 2020SA292550 (same reporter).  This case involves a 40-year-old patient (gender not specified) who had flu (influenza), after the patient received INFLUENZA VACCINE.  The past vaccinations included Influenza vaccine and the patient had flu last two times after getting the shot.  It was unknown if the patient had any concomitant disease, or risk factor.  Medical treatment, concomitant medication, and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number: not reported; expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   It was reported, the patient had flu three times.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of the event was unknown.  There will be no information available on batch number for this case.
Pt c/o itchiness and hives over whole body started this morning. pt denied fever, difficulty breathing, SOB, headache, dizziness, angioedema, chest discomfort, tachypnea and allergies to food.  Treatment: HYDROXYZINE HCL 25 MG TABS (HYDROXYZINE HCL) one to two tabs po every 6hrs as needed for itching, rash or allergy. PREDNISONE 20 MG TABS (PREDNISONE) two tabs po every morning with food, until asthma or allergy resolves.
felt achy; This spontaneous case was reported by a physician and describes the occurrence of PAIN (felt achy) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB for Psoriatic arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (felt achy). At the time of the report, PAIN (felt achy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information provided
PT'S MOM DELIBERATED LIED ON AGE WHEN FILLING PATIENT INTAKE FORM TO MAKE CHILD ELIGIBLE FOR COVID VACCINE VACCINATION AT THAT TIME. WE GOT AN EMAIL FROM DEPARTMENT OF HEALTH NOTIFYING US THAT WE GAVE PATIENT WHO WEREN'T ELIGIBLE AT THE TIME GIVEN.  WE WERE GIVEN FALSE INFORMATION BY MOTHER ON THE VACCINE INTAKE FORM.  WE WERE TOLD BY OUR STATE TO FILE A VAERS REPORT
Pain at injection site; Redness at injection site; blotchy at injection site; Itchiness at injection site; Fever; Fatigue; Aches; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Shingrix (1st dose received on unknown date, refer case US2019190822).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site reaction, injection site itching, fever, fatigue and pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site reaction, injection site itching, fever, fatigue and pain were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site reaction, injection site itching, fever, fatigue and pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient was a coworker. The reporter did not provide patient initial, date of birth or healthcare professional details. The patient received vaccine in unknown arm. The patient developed fever, pain at the injection site, aches, and fatigue and also developed itchiness, redness, and blotches at the injection site. The patient's symptoms lasted for a few days before resolving. The reporter had limited information regarding this adverse event. The reporter consent to follow up. This case had been linked to the case US2019190821, reported by same reporter.
pt recv vax;exp high fever of 40-45 C and may have a "coexisting kidney infection";seen in ER;
10:35 c/o redness and burning at site after vaccine. 11:27 c/o headache and dizziness. 11:50AM c/o numbness/tingling left arm, elevated blood pressure. Altered mental state. Tx: Monitor BP/ MD assessment at ER.
~5 minutes after receiving vaccinations, child had a sudden pain in chest/heaviness in chest and was short of breath. Also reported numbness in face. Medical staff assisted with having child lay down with legs elevated and kept warm, gave fluids (Gatorade). Event lasted ~ 2 minutes.  Child felt better after drinking Gatorade.
Shortness of breath 1/26/21 @7:30am Headache 1/26/21 @ 11:15am Fever  1/26/21 @11:30 98.9 ° Fever 1/26/21 @12:30pm 99.5°
pt recvd vax & devel t; given apap by mom for 24 hrs; called clinic, t 101-104; to clinic then sent to er; sepsis workup done because of inc sleepinesss; septic work up neg;
PATIENT SAID AREA STARTED ITCHING. SHE BOUGHT BENADRYL AND TOOK. DAYS LATER ARM BEGAN TO FEEL HOT, GOT RED AND SWOLLEN. PATIENT REPORTED TO ME ON MONDAY 02/08/2016. I OFFERED TO CALL AND MAKE DOCTOR'S APPOINTMENT, PATIENT DECLINED, SAID SHE WOULD CHECK WITH DOCTOR HERSELF. WAITED TO SEE HOW PATIENT DOING. CHECKED WITH PATIENT ON 02/13/2016, SAID ARM IS STILL A LITTLE SWOLLEN BUT REDNESS AND HEAT HAVE DISAPPEARED.
All foods haha be had a bad taste since vaccine resulting in significant weight loss, fatigue  decreased strength.
about 5 minutes after receiving vaccine patient felt light headed as if she may pass out, patient laid in floor with legs elevated, had her remove both masks to  get fresh air and gave her some water.  in about 2-3 minutes patient started feeling better got up in seat and proceeded to wait her required 15 minutes.  technician walked with patient up to front of store and she was feeling much better
On the area of Flu injection, warm erythematous area about 7x6 cm diameter. No pus discharge. Able to move arm well.
Patient administered with vaccine after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine after the manufacture date of expiration) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with vaccine after the manufacture date of expiration) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. The vial did not undergo any temperature excursions. Date vial was initially stored in the refrigerator was unknown. Total of 168 doses were given from LOT 048C21A with expiration date 09-Nov-2021. Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains non-significant information.
Client was lightheaded, dizzy, and then passed out. She continued to feel dizzy and lightheaded the rest of the day. The next day she was fine. It happened at school, right after lunch.
presenting to the emergency department with generalized weakness and symptoms of URI.  Tested positive for COVID-19 infection today.